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Abstract
 Background—Extreme values that arise for any reason, including through non-laboratory 
measurement procedure-related processes (inadequate mixing, evaporation, mislabeling), lead to 
outliers and inflate errors in recalibration studies. We present an approach termed iterative outlier 
removal (IOR) for identifying such outliers.
 Methods—We previously identified substantial laboratory drift in uric acid measurements in 
the Atherosclerosis Risk in Communities (ARIC) Study over time. Serum uric acid was originally 
measured in 1990–92 on a Coulter DACOS instrument using an uricase-based measurement 
procedure. To recalibrate previous measured concentrations to a newer enzymatic colorimetric 
measurement procedure, uric acid was re-measured in 200 participants from stored plasma in 
2011–13 on a Beckman Olympus 480 autoanalyzer. To conduct IOR, we excluded data points >3 
standard deviations (SDs) from the mean difference. We continued this process using the resulting 
data until no outliers remained.
 Results—IOR detected more outliers and yielded greater precision in simulation. The original 
mean difference (SD) in uric acid was 1.25 (0.62) mg/dL. After four iterations, 9 outliers were 
excluded, and the mean difference (SD) was 1.23 (0.45) mg/dL. Conducting only one round of 
outlier removal (standard approach) would have excluded 4 outliers (mean difference [SD] = 1.22 
[0.51] mg/dL). Applying the recalibration (derived from Deming regression) from each approach 
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to the original measurements, the prevalence of hyperuricemia (>7 mg/dL) was 28.5% before IOR 
and 8.5% after IOR.
 Conclusion—IOR is a useful method for removal of extreme outliers irrelevant to 
recalibrating laboratory measurements, and identifies more extraneous outliers than the standard 
approach.
 Introduction
In long-term cohort studies, clinical laboratories and laboratory measurement procedures 
(i.e., type of assay, instrument, or specimen) may change over time. For instance, different 
specimen types (plasma versus serum) may be used at different time points, and modern 
instruments may replace older ones. These changes can result in substantial between-assay 
variation (laboratory drift). It is crucial to periodically evaluate laboratory drift in 
longitudinal studies and, if present, to re-calibrate measurements to ensure alignment of 
values across study visits. This laboratory recalibration is especially important for analyses 
of trends over time. Proper implementation of a laboratory recalibration study includes 
parsing out different sources of error. Outliers often occur in such laboratory recalibration 
studies. Extreme values that arise through a process unrelated to the laboratory measurement 
procedure, such as inadequate mixing, evaporation, degradation, mislabeling, or data entry 
errors are not informative about the recalibration of the vast majority of samples where such 
errors did not occur. In fact, these outliers can decrease precision and increase the error in 
the derived recalibration regression. Therefore, distinguishing between error related and 
unrelated to the laboratory measurement procedure is critical but challenging.
The general principles of how one might handle outliers in clinical chemistry applications 
have been previously outlined. More specifically, various approaches have been described to 
identify and minimize the effect of outliers when comparing measurements in laboratory 
recalibration studies.– These approaches must be balanced with the risk of omitting too 
many data points and artificially improving agreement. In general, it is good practice to 
evaluate and report the percentage of outliers identified and to evaluate the laboratory 
measurement procedure error after exclusion of these outliers. We present here an Iterative 
Outlier Removal (IOR) method, a straightforward and efficient approach to identifying 
outliers that are likely irrelevant to the recalibration process. We use data from a laboratory 
recalibration study on uric acid in a large prospective cohort, the Atherosclerosis Risk in 
Communities (ARIC) Study, to demonstrate the utility of the IOR approach; and conduct a 
simulation to compare the effect of IOR to that of a standard outlier removal approach.
 Methods
 Study population
The ARIC Study is an ongoing community-based cohort of 15,792 adults from four 
communities in the United States. There have been five main clinic examinations. The first 
examination (visit 1) took place from 1987–1989 with three follow-up examinations 
occurring approximately three years apart during 1990 to 1992 (visit 2), 1993 to 1995 (visit 
3), and 1996 to 1998 (visit 4). A fifth examination was completed in 2011–13. An 
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institutional review board at each site approved all procedures, and all study participants 
provided written informed consent.
We previously undertook a laboratory recalibration study to align measurements taken over 
the five ARIC visits that were conducted in two different laboratories at different times up to 
25 years apart, using different assays, instruments, and specimen types. A recalibration 
subsample consisting of blood samples from 200 ARIC participants was selected for re-
assay of blood analytes in stored specimens. We present here the results for the recalibration 
of uric acid measurements at visit 2 to demonstrate the IOR method for outlier identification 
and exclusion.
 Laboratory measurement procedures
Uric acid was originally measured in serum at visit 2 (1990–92) at the University of 
Minnesota using the Coulter DACOS system using an uricase measurement procedure (inter-
assay CV=2.7%). The recalibration study was performed on the 200 samples from each 
ARIC visit in stored plasma in 2011–13 at Baylor College of Medicine using the Beckman 
Olympus AU 480 using an enzymatic colorimetric measurement procedure (CV=1.8%). For 
this paper, we use only visit 2 measurements.
 Iterative Outlier Removal (IOR) method
To identify outliers unrelated to laboratory measurement procedure error and likely not 
relevant to the recalibration process, we undertook the following steps to compare the uric 
acid values measured in 1990–92 to those measured in 2011–13 in the 200 participants with 
both available values:
1. We calculated the mean difference, where the difference for each participant 
was calculated as the original value minus the re-measured value. We identified 
and excluded data points for which the difference was >3 standard deviations 
(SDs) away from the mean difference.
2. We then calculated the mean difference and corresponding SD after excluding 
the previously identified outlying data points. We identified and excluded data 
points for which the difference was > 3 SDs away from this new mean 
difference. We repeated step #2 and continued this iterative process until no 
outliers remained.
The IOR process was considered complete when all differences lie within the 3 SDs of the 
mean difference. When non-constant bias is suspected since the slope of the regression of 
new values on old values is very different from 1.0, this method can be applied to the 
residual from the regression rather than differences.
 Comparison with standard approach using ARIC data and simulations
For comparison, we used a standard approach of one round of identifying data points outside 
of the 3 SDs from the mean difference. We compared the mean values, mean difference and 
SD, recalibration equations, and prevalence of hyperuricemia (uric acid >7.0 mg/dL) that 
resulted from the standard and IOR approaches.
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As a second method of comparing the implications of using a standard approach of 
conducting one round of outlier removal to IOR, we conducted 500 rounds of simulations. 
To do this, we created a data set of 1,000 observations randomly selected from a normal 
distribution with mean 100 and SD=10 as the unobserved true values. To simulate the 
original values, we added measurement error with a normal distribution with mean zero and 
SD=10. To simulate the reference value measured later, we added two sources of error: (1) 
measurement error with a normal distribution with mean zero and SD=10 that is independent 
of the original measurement and (2) outlier error with a normal distribution with mean of +/
−60 and SD=10 with this latter part only included randomly with a fixed frequency 
(Bernoulli distribution with probability of either 1%, 5%, or 10% simulating a higher 
fraction of outliers) and 50/50 distribution of positive and negative sign. The difference 
between the reference and true measurements reflects the total amount of measurement 
error. We also conducted supplemental analyses that specified fixed error rates of 0%, 1%, 
5%, 10%, 20%, 30%, 40%, and 50%; and an asymmetric distribution of the outliers (75% 
and 100% of the outliers on the positive side of the sample).
For each of the simulation scenarios we removed outliers using two approaches: a standard 
approach of one round of removing outliers >3 SDs from the mean difference, and the IOR 
approach. We then calculated the mean and SD of the difference of the two measurements, 
the slope of the difference versus the mean and its standard error, and the intercept of the 
difference versus the mean and its standard error; and then calculated the mean and SD, as 
well as the median and 5th and 95th percentiles of each of these results. For each of the 
outlier removal approaches, we also calculated the proportion of observations that were 
identified as outliers and removed.
 RESULTS
We present descriptive statistics of the original and reference uric acid measurements (Table 
1). The scatterplot of the uric acid reference measurement against the original measurement, 
including the line of equality (Y=X), Pearson correlation coefficient, and regression 
coefficients and SDs are shown in Figure 1. To illustrate the IOR method, we present a 
Bland-Altman plot that indicates the outliers that were identified and excluded after each 
iteration of IOR (Figure 2). We conducted four iterations of IOR before we obtained a 
sample with no values greater than 3 SDs away from the mean difference. We identified 9 
outliers (4.5% of data points) after four iterations of IOR for uric acid.
IOR identified 4.5% of data points as outliers. We re-calculated descriptive statistics and 
regenerated a scatterplot after exclusion of these outliers. The mean difference (original 
minus re-measured measurements) was 1.25 mg/dL before IOR and 1.23 mg/dL after IOR 
(Table 1). The SD of the mean difference was notably larger before versus after IOR (0.62 
versus 0.45, respectively (Table 1). After IOR, the Pearson correlation coefficient was higher 
(0.947 versus 0.902) and the standard error of the regression line coefficient was smaller, as 
can be seen in the comparison of the scatterplots (Figure 1). Additionally, the standard error 
of the regression of the mean difference versus the mean of the uric acid measurements 
became smaller after each iteration of IOR (Table 2).
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We then used Deming regression to calibrate the original measurement to the reference 
measurement, using the data set that excluded all outliers identified by IOR. The resulting 
recalibration equation was: calibrated uric acid = −0.47 + 0.88*original uric acid.
If we had only conducted one round of outlier removal, we would have identified four 
outliers, instead of nine. After exclusion of these four outliers, the resulting recalibration 
equation from Deming regression would have been: −0.43 + 0.87*original uric acid. After 
applying this recalibration equation to the original uric acid measurements in the 200 
participants, the prevalence of hyperuricemia was slightly lower than when using IOR (Table 
1).
Results of our simulation study further support the use of IOR as a useful method for 
identifying and removing outliers. As the proportion of measurements with both 
measurement error and additional error from other processes increased from 1% to 10%, the 
inflation in the SD of the difference between measurements increased (median SDs were 15, 
20, and 24 for error rates of 1, 5, and 10%, respectively) (Table 3). After conducting only 
one round of outlier removal, the issue of inflated SDs remained, but was not quite as severe. 
Further proceeding with multiple iterations of outlier removal using the IOR approach 
resulted in SDs that were no longer inflated (median SDs were 14.0, 14.3, and 14.8) (Table 
3). IOR detected more outliers than conducting just one round of outlier removal (median 
proportion of observations identified as outliers were 1.10 vs 0.9%, 4.4 vs 2.6%, and 8.3 vs 
2.5%, for error rates of 1, 5, and 10%, respectively) (Table 3). IOR even performed well in 
the setting of asymmetric distribution of the outliers, as evidenced by SDs that were no 
longer inflated and a greater proportion of outliers observed compared to the standard 
approach (Supplemental Table 1). However, when the rate of outliers was very high (20% or 
greater) the IOR method no longer worked, presumably since the outliers now changed the 
whole distribution; SDs remained inflated and the proportion of outliers detected was low 
(median proportion of observations identified as outliers were 1.0%, 0.1%, 0.0%, and 0.0% 
for 20%, 30%, 40%, and 50% error rates, respectively) (Supplemental Table 2).
In the case of asymmetric distribution of the outliers, IOR performed better than the standard 
approach.
 Discussion
We recommend the use of an IOR approach to identify outliers that are most likely due to 
processes that are different from the laboratory measurement procedure, such as sample 
evaporation and/or degradation or specimen mislabeling. It is important to clarify that 
exclusion of outliers is not conducted to artificially improve agreement of measurements. 
Laboratory recalibration is intended to correct for laboratory measurement procedure-related 
processes such as assays being conducted using different instruments, in different 
laboratories, or different specimen types. Therefore, it is useful to remove outliers arising 
from processes that are either different from laboratory measurement procedures or may be 
the result of an issue with the measurement procedure itself, such as interference that is 
larger than usual measurement error and hence produces outliers.
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A classical measurement error model assumes that the error is normally distributed with a 
given variance. However, we have assumed that the error is a mixture of a normal 
distribution with a small variance and a normal distribution with a large variance (errors 
related and unrelated to laboratory-measurement procedure variability, respectively). IOR 
can help distinguish data points resulting from these two types of errors, and intends to 
exclude data points coming from the distribution with the larger variance. This formulation 
also applies to the calculation of the difference of the original and reference measurements.
The purpose of any approach to outlier removal is to minimize the influence of error due to 
factors other than those we are trying to account for during the recalibration process. 
Including measurements due to extraneous error processes could introduce unwanted noise 
into a recalibration equation. Indeed, we noted that after each iteration of IOR, the standard 
error of the regression line coefficient decreased. Previous methods have typically relied on 
one or two rounds of outlier removal, which attempts to remove extreme outliers.– However, 
these methods have not assessed the distribution of remaining data points after these outliers 
are removed, and the potential for any residual unrelated error. Our iterative approach 
proposes to remove any additional remaining extreme values that are due to these extraneous 
error processes. Compared to a standard approach of conducting one round of outlier 
removal, IOR enables us to identify a greater proportion of these outliers that are irrelevant 
to recalibration. We are then able to conduct Deming regression or implement another 
appropriate recalibration approach using only those data points that are representative of the 
expected laboratory measurement procedure variability, resulting in a more accurate 
recalibration equation. However, the use of IOR is limited in the setting of a high error rate 
(≥20%), in which it did not perform any better than the standard approach. Furthermore, as 
has previously been noted, if outliers are too close to the 3 SD threshold, they will not be 
identified by the IOR approach, since they will influence the estimate of the SD. Whereas 
differences in results between IOR and conducting one round of outlier removal may seem 
subtle, we propose that IOR results in a more accurate recalibration of measurements in 
many situations.
It is crucial to use outlier removal methods that are transparent and easily replicated, and can 
be easily communicated and understood by the scientific community. IOR fulfills these 
criteria and can be conducted using standard statistical software. We have demonstrated this 
accessible approach to identify data points that are extraneous to the recalibration process, 
which may be useful for clinical chemists, epidemiologists, lab scientists, and other 
investigators who have data that require recalibration.
 Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Scatterplots of reference versus original uric acid measurements, before and after 
iterative outlier removal
Pearson correlation coefficients for the reference versus original uric acid measurements are 
presented in each of the scatterplots. Beta coefficients and corresponding standard errors for 
the regression line are also reported.
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Figure 2. Bland-Altman plot of uric acid with all outliers identified during iterative outlier 
removal
The horizontal dashed line indicates a difference of zero. The solid black lines indicate the 
mean difference and +/− 2 standard deviations from the mean difference (calculated after 
exclusion of outliers). The dashed line indicates the regression line (after exclusion of 
outliers). We present outliers identified during each iteration of iterative outlier removal 
(IOR).
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Table 1
Descriptive statistics of uric acid before outlier removal, after one round of outlier removal, and after iterative 
outlier removal
Before IOR
(N=200)
After 1
round of
outlier
removal
(N=196)
After IOR
(N=191)
Mean (SD)
(mg/dL)
or %
Mean (SD)
(mg/dL)
or %
Mean (SD)
(mg/dL)
or %
Original 6.41 (1.44) 6.35 (1.39) 6.36 (1.38)
Reference 5.17 (1.30) 5.13 (1.23) 5.12 (1.23)
Difference (Original-Reference) 1.25 (0.62) 1.22 (0.51) 1.23 (0.45)
Mean of Original and Reference 5.79 (1.34) 5.74 (1.28) 5.74 (1.29)
Hyperuricemia, %* 28.5% 7.5% 8.5%
Abbreviations: IOR, iterative outlier removal
*
Hyperuricemia defined as uric acid >7.0 mg/dL
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Table 2
Beta coefficients and standard errors of the regression lines of the difference versus mean uric acid 
measurements after each iteration of IOR
N remaining Beta (SE)
Before IOR 200 0.10 (0.032)
After 1st iteration 196 0.13 (0.027)
After 2nd iteration 194 0.12 (0.026)
After 3rd iteration 192 0.12 (0.025)
After 4th iteration 191 0.12 (0.024)
Abbreviations: IOR, iterative outlier removal; SE, standard error
The beta coefficients and SEs were obtained from the regression line of the difference between uric acid measurements (original minus reference) 
versus the mean of uric acid measurements
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Table 3
Simulation to compare original and reference measurements before outlier removal, after one round of outlier 
removal, and after iterative outlier removal
Bernoulli success probability: p=0.01 p=0.05 p=0.10
Before outlier removal
(N=1,000)
  Mean of Difference
Mean (SD) 0.01 (0.49) 0.04 (0.62) 0.06 (0.74)
Median (5th–95th)* 0.03 (−0.78, 0.80) 0.09 (−0.96, 1.04) 0.10 (−1.31, 1.21)
  SD of Difference
Mean (SD) 15.4 (0.5) 19.6 (0.8) 23.9 (0.9)
Median (5th–95th)* 15.4 (14.6, 16.2) 19.6 (18.3, 20.9) 23.9 (22.4, 25.4)
  Slope of difference vs. mean
Mean (SD) 0.12 (0.05) 0.47 (0.07) 0.76 (0.06)
Median (5th–95th)* 0.12 (0.03, 0.21) 0.47 (0.36, 0.58) 0.77 (0.66, 0.86)
  Standard error of Slope of
  difference vs. mean
Mean (SD) 0.04 (0.00) 0.04 (0.00) 0.04 (0.00)
Median (5th–95th)* 0.04 (0.04, 0.04) 0.04 (0.04, 0.04) 0.04 (0.04, 0.04)
  Intercept of difference vs. mean
Mean (SD) 0.01 (0.48) 0.04 (0.57) 0.04 (0.64)
Median (5th–95th)* 0.03 (−0.77, 0.78) 0.06 (−0.98, 0.93) 0.07 (−1.05, 1.10)
  Standard error of Intercept of
  difference vs. mean
Mean (SD) 0.48 (0.01) 0.58 (0.02) 0.65 (0.02)
Median (5th–95th)* 0.48 (0.46, 0.51) 0.58 (0.55, 0.61) 0.65 (0.63, 0.68)
After one round of outlier
removal
  Mean of Difference
Mean (SD) 0.02 (0.45) 0.03 (0.55) 0.07 (0.72)
Median (5th–95th)* 0.03 (−0.70, 0.73) 0.03 (−0.83, 0.90) 0.06 (−1.10, 1.23)
  SD of Difference
Mean (SD) 14.1 (0.3) 15.8 (0.6) 20.3 (1.2)
Median (5th–95th)* 14.1 (13.5, 14.7) 15.7 (14.8, 16.9) 20.3 (18.4, 22.3)
  % Observations identified as
  outliers and removed
Mean (SD) 0.91 (0.25) 2.62 (0.31) 2.49 (0.35)
Median (5th–95th)* 0.90 (0.50, 1.35) 2.60 (2.10, 3.10) 2.50 (1.90, 3.05)
  Slope of difference vs. mean
Mean (SD) 0.02 (0.04) 0.19 (0.06) 0.55 (0.08)
Median (5th–95th)* 0.02 (−0.05, 0.08) 0.19 (0.09, 0.29) 0.56 (0.42, 0.69)
  Standard error of Slope of
  difference vs. mean
Mean (SD) 0.04 (0.00) 0.04 (0.00) 0.04 (0.00)
Median (5th–95th)* 0.04 (0.03, 0.04) 0.04 (0.04, 0.04) 0.04 (0.04, 0.04)
  Intercept of difference vs. mean
Mean (SD) 0.02 (0.45) 0.02 (0.53) 0.06 (0.65)
Median (5th–95th)* 0.04 (−0.70, 0.72) 0.04 (−0.82, 0.87) 0.07 (−1.02, 1.15)
  Standard error of Intercept of
  difference vs. mean
Mean (SD) 0.45 (0.01) 0.50 (0.02) 0.59 (0.02)
Median (5th–95th)* 0.45 (0.43, 0.47) 0.50 (0.47, 0.53) 0.59 (0.56, 0.63)
After IOR
  Mean of Difference
Mean (SD) 0.02 (0.45) 0.02 (0.50) 0.01 (0.53)
Median (5th–95th)* 0.05 (−0.67, 0.77) 0.02 (−0.77, 0.83) 0.03 (−0.88, 0.85)
  SD of Difference
Mean (SD) 14.0 (0.3) 14.3 (0.4) 14.8 (0.6)
Median (5th–95th)* 14.0 (13.4, 14.5) 14.3 (13.6, 15.0) 14.8 (13.9, 15.8)
  % Observations identified as
  outliers and removed
Mean (SD) 1.16 (0.35) 4.45 (0.72) 8.30 (0.92)
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Bernoulli success probability: p=0.01 p=0.05 p=0.10
Median (5th–95th)* 1.10 (0.60, 1.70) 4.40 (3.20, 5.60) 8.30 (6.80, 9.85)
  Slope of difference vs. mean
Mean (SD) 0.01 (0.04) 0.05 (0.04) 0.12 (0.06)
Median (5th–95th)* 0.01 (−0.05, 0.07) 0.05 (−0.02, 0.12) 0.12 (0.03, 0.22)
  Standard error of Slope of
  difference vs. mean
Mean (SD) 0.04 (0.00) 0.04 (0.00) 0.04 (0.00)
Median (5th–95th)* 0.04 (0.03, 0.04) 0.04 (0.03, 0.04) 0.04 (0.04, 0.04)
  Intercept of difference vs. mean
Mean (SD) 0.02 (0.45) 0.02 (0.49) 0.01 (0.52)
Median (5th–95th)* 0.05 (−0.68, 0.76) 0.02 (−0.76, 0.81) 0.04 (−0.86, 0.83)
  Standard error of Intercept of
  difference vs. mean
Mean (SD) 0.44 (0.01) 0.46 (0.01) 0.49 (0.02)
Median (5th–95th)* 0.45 (0.43, 0.46) 0.46 (0.44, 0.48) 0.49 (0.46, 0.51)
We conducted 500 simulations, specifying a bimodal normal distribution with a mean of +/−60 and a standard deviation of 10.
*We present the median and corresponding 5th and 95th percentiles, or the empirical 90% confidence interval.
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